Suchergebnisse - "*Antirheumatic Agents"

PubPharm (30.208)

11

Using explainable artificial intelligence to predict and forestall flare in rheumatoid arthritis

enthalten in: Nature medicine | 2024

von Alivernini, S. | Cañete, J. | Bacardit, J. | +1

12

Anti-tumor necrosis factor (aTNF) weaning strategy in juvenile idiopathic arthritis (JIA) : does duration matter?

enthalten in: Clinical rheumatology | 2024

von Teh, K. | Das, L. | Book, Y. | +3

13

Incidence of Uveitis in Patients With Axial Spondylarthritis Treated With Biologics or Targeted Synthetics : A Systematic Review and Network Meta-Analysis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2024

von Bechman, K. | Yang, Z. | Adas, M. | +7

14

The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis

enthalten in: Annals of internal medicine | 2024

von Narula, K. | Lazarus, K. | Choudhury, S. | +1

15

The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis

enthalten in: Annals of internal medicine | 2024

von Theophilopoulos, A. | Bubb, M.

16

The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis

enthalten in: Annals of internal medicine | 2024

von Palmowski, A. | Boers, M. | Kirwan, J. | +2

17

Therapeutic Drug Monitoring : A Tool to Optimize Treatment of Inflammatory Joint Diseases

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2024

von Syversen, S. | Gehin, J. | Goll, G. | +3

18

Infliximab Concentrations in Participants with Moderate to Severe COVID-19

enthalten in: Journal of clinical pharmacology | 2024

von Balevic, S. | Dandachi, D. | Dixon, D. | +4

19

Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis : 3-year results of a prospective, multicenter, observational study

enthalten in: Arthritis research & therapy | 2024

von Yamada, Z. | Muraoka, S. | Kawazoe, M. | +5

20

Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia

enthalten in: Clinical rheumatology | 2024

von An, Q. | Ma, R. | Yuan, D. | +8